Miranova (Ethinylestradiol, Levonorgestrel)

Ethinylestradiol, the active ingredient in Miranova, is a combined oral contraceptive presented as a tablet for oral use. Together with levonorgestrel, it works to prevent pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus. It is indicated for women seeking a convenient, reversible method of birth control and is marketed in the European Union.

GNH USA supplies Miranova as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Miranova, a combined oral contraceptive, is used to manage reproductive health and related hormonal conditions.

Pregnancy prevention: provides reliable contraception for women of childbearing age. Menstrual cycle regulation: helps achieve more predictable periods and reduces menstrual discomfort. Acne management: can improve hormone‑related acne in some women.

Miranova may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild stomach upset, especially when therapy begins. - Breast tenderness: temporary swelling or soreness. - Headache: mild to moderate tension‑type headaches. - Spotting between periods: irregular bleeding early in therapy.

Serious or Rare Side Effects: - Thromboembolic events: deep‑vein thrombosis or pulmonary embolism. - Cardiovascular events: stroke or myocardial infarction. - Severe allergic reaction: rash, swelling, or anaphylaxis.

Before prescribing Miranova, clinicians should evaluate patient‑specific risk factors and counsel on safe use.

Assess risk of thrombosis: evaluate personal and family history of clotting disorders. Avoid smoking: especially in women over 35 years of age. Monitor blood pressure: ensure hypertension is controlled before initiation. Consider liver function: assess for hepatic disease that may affect metabolism. Review medication list: check for interacting drugs that could reduce efficacy. Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Miranova can interact with several medicines, altering its contraceptive effectiveness.

Major Interactions (Avoid): - Antiepileptic enzyme inducers (e.g., carbamazepine, phenytoin): may reduce efficacy. - Rifampicin: decreases hormone levels, increasing risk of contraceptive failure. - Certain HIV protease inhibitors (e.g., ritonavir): may alter hormone metabolism.

Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., ketoconazole): may increase hormone levels. - St. John’s wort: may lower effectiveness. - Antibiotics (e.g., tetracycline): possible reduced absorption.